Suppression of fungal growth exhibited by Pseudomonas aeruginosa
- PMID: 8150966
- PMCID: PMC263067
- DOI: 10.1128/jcm.32.2.525-527.1994
Suppression of fungal growth exhibited by Pseudomonas aeruginosa
Abstract
Three surgery patients were monitored postoperatively, with particular reference to lung infection. In each case there was a clinical impression that Pseudomonas aeruginosa suppressed the growth of Candida albicans in patients with clinically significant lung infections from whom both of these organisms were isolated from serial sputum samples. Regrowth of C. albicans after P. aeruginosa eradication occurred in two patients, despite fluconazole therapy, to which both C. albicans isolates were susceptible. In all three patients, the strain of P. aeruginosa was found to inhibit the growth of the corresponding C. albicans strain in vitro. Further in vitro susceptibility studies revealed significant inhibition by 10 strains of P. aeruginosa of 11 strains of fungi known to infect humans; these were Candida krusei, Candida keyfr, Candida guillermondii, Candida tropicalis, Candida lusitaniae, Candida parapsilosis, Candida pseudotropicalis, Candida albicans, Torulopsis glabrata, Saccharomyces cerevisiae, and Aspergillus fumigatus.
Similar articles
-
Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis.J Infect. 1994 May;28(3):305-10. doi: 10.1016/s0163-4453(94)91943-7. J Infect. 1994. PMID: 7522262
-
Inhibition of growth of fungi pathogenic to man by Stenotrophomonas maltophilia.J Med Microbiol. 1996 Nov;45(5):380-2. doi: 10.1099/00222615-45-5-380. J Med Microbiol. 1996. PMID: 8918956
-
Anticandidal activity of Pseudomonas aeruginosa strains isolated from clinical specimens.Mycoses. 2007 Jan;50(1):74-8. doi: 10.1111/j.1439-0507.2006.01322.x. Mycoses. 2007. PMID: 17302753
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.J Hosp Infect. 2002 Apr;50(4):243-60. doi: 10.1053/jhin.2001.1151. J Hosp Infect. 2002. PMID: 12014897 Review.
Cited by
-
Importance of selective media for recovery of yeasts from clinical specimens.J Clin Microbiol. 1999 Nov;37(11):3731-2. doi: 10.1128/JCM.37.11.3731-3732.1999. J Clin Microbiol. 1999. PMID: 10523586 Free PMC article.
-
Pathogenetic Impact of Bacterial-Fungal Interactions.Microorganisms. 2019 Oct 16;7(10):459. doi: 10.3390/microorganisms7100459. Microorganisms. 2019. PMID: 31623187 Free PMC article. Review.
-
Antagonistic Interaction of Staphylococcus aureus Toward Candida glabrata During in vitro Biofilm Formation Is Caused by an Apoptotic Mechanism.Front Microbiol. 2018 Aug 30;9:2031. doi: 10.3389/fmicb.2018.02031. eCollection 2018. Front Microbiol. 2018. PMID: 30214437 Free PMC article.
-
Inter-kingdom encounters: recent advances in molecular bacterium-fungus interactions.Curr Genet. 2009 Jun;55(3):233-43. doi: 10.1007/s00294-009-0241-2. Epub 2009 Apr 1. Curr Genet. 2009. PMID: 19337734 Review.
-
Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis.PLoS Pathog. 2015 Aug 27;11(8):e1005129. doi: 10.1371/journal.ppat.1005129. eCollection 2015 Aug. PLoS Pathog. 2015. PMID: 26313907 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical